A door-to-balloon (D2B) time of 90-minutes or less is associated with improved outcomes for heart attack patients. However, during the COVID-19 pandemic certain obstacles—including the need for COVID-19 screening, associated ...
Oct 4, 2023
0
8
Patients who quit smoking after undergoing percutaneous coronary intervention (PCI) for narrowed arteries have similar outcomes as non-smokers during four years of follow-up after the procedure, according to a large study ...
Sep 26, 2023
0
1
New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October) shows that following a heart attack, there have been falls in the ...
Sep 12, 2023
0
4
Severe heart attacks often progress to end-stage heart failure because the dearth of heart muscle cells diminishes pumping power of the heart's left ventricle. The damaged heart, unable to repair itself, deteriorates and ...
Sep 11, 2023
0
2
Red blood cells exposed to oxygen deficiency protect against myocardial infarction, according to a new study published in the Journal of Clinical Investigation. The study also shows that the protective effect is enhanced ...
Sep 1, 2023
0
4
The use of active mechanical circulatory support is growing rapidly around the world. The hope is that these systems will improve survival after the most severe form of acute heart failure, cardiogenic shock.
Aug 30, 2023
0
30
For patients with non-ST segment elevation myocardial infarction (NSTEMI), hospital COVID-19 burden was associated with worse outcomes and treatments but did not affect race and ethnicity-associated inequities, according ...
Aug 30, 2023
0
12
Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking research presented in ...
Aug 29, 2023
0
1
Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial infarction complicated by cardiogenic shock who are scheduled for early revascularization, according to late breaking research ...
Aug 28, 2023
0
1
The largest randomized controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking research presented in a Hot Line session today, August 28, at ...
Aug 28, 2023
0
18
